MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/neuonc/noag155

Медицинская библиотека · Neuro-oncology · 2026

FUS-mediated BBB opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients.

Del Bene Massimiliano, Osti Daniela, Bonada Marta, Pascuzzo Riccardo, Piccardi Annica, Carone Giovanni, Meanti Lisa, Stanziano Mario, Caldiera Valentina, Carozzi Carla, Silvani Antonio, Ciceri Elisa Francesca Maria, Grisoli Marina, Pelicci Giuliana, DiMeco Francesco

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Focused ultrasound-mediated blood-brain barrier opening (BBBO) is hypothesized to enhance liquid biopsy by facilitating the release of tumor material into the circulation. This study aimed to evaluate the impact of MR-guided FUS-BBBO on plasma extracellular vesicle (EV) concentrations and size distributions, alongside cell-free DNA (cfDNA) profiles, to determine the clinical efficacy of this approach in glioblastoma (GB) patients.

METHODS

We performed 14 MR-guided focused ultrasound (FUS)-BBBO procedures in patients with GB with blood sampling 1 h before and 1 h after sonication. Plasma EVs were isolated by size-exclusion chromatography and quantified by tunable resistive pulse sensing technology. Cell-free DNA (cfDNA) concentration and fragment profiles were assessed using fluorometric and electrophoretic methods.

RESULTS

EV concentration showed no consistent change after FUS-BBBO, with marked inter-patient and inter-procedure heterogeneity. In contrast, EV size displayed a reproducible diameter reduction of ∼8-10 nm, driven predominantly by contraction of the upper tail of the size distribution, indicating selective modulation of larger vesicle subpopulations. cfDNA concentrations and fragmentation showed a heterogeneous pattern, with occasional patient-specific increases. Exploratory analyses revealed no significant associations between biomarker changes and procedural parameters except for treated volume.

CONCLUSIONS

Our findings challenge the assumption that clinical BBBO uniformly increases biomarker abundance. The consistent shift toward smaller EVs suggests a selective modulation rather than an increased release. While BBBO may enhance the detectability of analytes that poorly cross the BBB, this may not apply to EVs, which are able to traverse the BBB under physiological conditions, further supporting their value as liquid-biopsy substrates in neuro-oncology. Future studies integrating clinical data with mechanistic models are necessary to refine FUS-enhanced diagnostic strategies.

Для цитирования: Del Bene Massimiliano, Osti Daniela, Bonada Marta, Pascuzzo Riccardo, Piccardi Annica, Carone Giovanni, Meanti Lisa, Stanziano Mario, Caldiera Valentina, Carozzi Carla, Silvani Antonio, Ciceri Elisa Francesca Maria, Grisoli Marina, Pelicci Giuliana, DiMeco Francesco. FUS-mediated BBB opening reshapes plasma extracellular vesicle size distribution without elevating concentration in glioblastoma patients.. Neuro-oncology. 2026. DOI: 10.1093/neuonc/noag155.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.